Physician profile
Daniel E Gelman
NPI 1346702040
$9,232.31
in general payments reported to CMS, 2019-2025
11 companies · $1,826 in 2025
The $1,826 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,996 · 2022: $1,753 · 2023: $1,323 · 2024: $1,334 · 2025: $1,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068 · Travel and Lodging: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,068.41 |
| Travel and Lodging | $1,415.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,713.41 | 2021-2022 | |
| Stryker Corporation | $2,645.94 | 2021-2025 | Axsos, Augment Injectable, Variax |
| Arthrex, INC. | $1,185.97 | 2024-2025 | |
| Team 1, LLC | $726.78 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $224.59 | 2022-2024 | Persona |
| Sanara Medtech INC. | $221.48 | 2022-2024 | Celleraterx |
| Acumed LLC | $132.50 | 2024 | Acumed, Innate Implant |
| Si-Bone, INC. | $125.00 | 2021 | |
| Skeletal Dynamics INC | $116.28 | 2024 | Ijs, Geminus, Implate |
| Checkpoint Surgical, INC | $96.97 | 2023 | Checkpoint Stimulators |
| Mission Medical Distribution, LLC | $43.39 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.